DISSECTING SECTION 3 OF THE INDIAN PATENTS ACT
- 6 days ago
- 3 min read
Section 3 of the Indian Patents Act contains a lengthy list of what inventions are not
patentable in India. However, what makes Section 3 fascinating is the presence of certain
words that may act as a gateway to interpretation and/or understanding the intent of the
legislature. In this article, we delve into some such words.

Section 3(c) – Delineating Invention from Discoveries
Section 3(c) prohibits the patenting of mere discoveries of scientific principles, formulation
of abstract theories, or discovery of any living thing or non-living substance occurring in
nature. Fairly straightforward to interpret, what’s the catch, you may wonder? Well, the catch
lies in the presence of the word “mere”, before “discovery of a scientific principle”. Here, the
word “mere” stands for “nothing more than”.
Therefore, Section 3(c) only prohibits patenting of inventions that are nothing more than a
discovery. In other words, if an invention requires at least some experimentation to be arrived
at (as compared to only exploration and observation), it may fall outside the purview of
Section 3(c).
Section 3(d) – Separating the Adults from the Kids
Among other things, Section 3(d) prohibits the patenting of mere discoveries of new form of
known substances which do not result in the enhancement of the known efficacy of those
substances. Here, again, the catch lies in the presence of the word “mere”, before “discovery
of a new form of a known substance”. In addition, the presence of the word “efficacy” creates
a further complication, which has subsequently been clarified by the Supreme Court to refer
to “therapeutic efficacy” (pharmacodynamic characteristics).
Having said that, in the matter of Indian Patent Application Numbered 202337012007, the
Controller held that improved drug release and bioavailability constitute valid technical
Effects!
Oh, and another letter that deserves attention is one that we often pay the least attention to,
which is the letter “a”, as in “a new form of a known substance”. It’s another matter
altogether that the Patent Office invokes Section 3(d), by mosaicing multiple documents,
which is not permissible.
Section 3(k) – The per se Conundrum
Section 3(k) prohibits mathematical or business methods or computer programmes per se or
algorithms. What’s the fuss, you may wonder? Well, it surrounds the two words “per se” (a
Latin expression that means “by itself”), which appear after “computer programme”.
Thus, only inventions that are by themselves computer programmes are not patentable. The
Courts have subsequently clarified that inventions must be examined holistically. The Courts
have further held that technical effect and technical contribution are to be given due
consideration, in determining whether an invention falls under the purview of Section 3(k).
Section 3(p) – The Biopiracy Safeguard
Section 3(p) prohibits inventions that in effect, are traditional knowledge or which are an
aggregation or duplication of known properties of traditionally known component or
components. The phrase “in effect” stands for “in fact”. While other important subsections of
Section 3 have received the Courts’ attention, to a certain extent, Section 3(p) still has a long
way to go.
For example, if an invention relates to a composition comprising ten ingredients, and a TKDL
(Traditional Knowledge Digital Library) document discloses four of the ten ingredients, as
part of a larger composition comprising thirty five ingredients, does the invention still fall
under the purview of Section 3(p)?
What is the specific teaching, suggestion, or motivation to pick out those four ingredients
from the thirty five ingredients, and combine the same, with the teachings of other
documents, to arrive at the claimed invention? On whom does the burden of proof lie? Does
the applicant have to recreate the cited document’s invention with 35 ingredients, and
generate comparative data, to prove technical superiority?
Have an invention in hand, but don’t know how to proceed further? Confused whether you
should file for a patent or a copyright? Fret not, your friendly neighbourhood patent
professionals are just a phone call or email away.



